Commentary
340B
340B Drug Pricing Program Overdue for Reform, GOP Can Help
Members of the Senate Health, Education, Labor, and Pensions Committee held a hearing in October to discuss a federal healthcare policy long overdue for reform — the 340B Drug Pricing Program. Created to expand access to affordable medicines for low-income people, 340B has since fallen victim to rampant abuse by ...
Commentary
Medicare’s Paltry Doctor Payments Are Price Controls In Disguise
Specialist physicians will receive a significant pay cut from Medicare next year. That’s the main takeaway from the 2026 physician fee schedule released by the Centers for Medicare and Medicaid Services in October. For years, physician reimbursement from Medicare has stagnated, even declined. Doctors are responding by leaving the profession ...
Commentary
Restricting Capital Investment Is A Losing Energy Strategy
The U.S. energy grid stands at a crossroads. It is facing an unprecedented rise in electricity demand driven in no small part by the growth of artificial intelligence and high-tech manufacturing. Simultaneously, supply is being curtailed by growing power plant retirements. It doesn’t take an advanced degree in economics to ...
Commentary
No, the expiring subsidies aren’t to blame for next year’s premium hikes
Open enrollment on Obamacare‘s exchanges is upon us. People shopping for coverage will be greeted by higher premiums. According to one recent analysis from the Peterson-KFF Health System Tracker, premiums for 2026 coverage will rise by 18 %. Out-of-pocket costs could go up hundreds or thousands of dollars, according to ...
Commentary
Medicare Wasn’t Broken Until Democrats Made It That Way
Seniors shopping for a prescription drug plan during this year’s Medicare open enrollment season are in for an unpleasant surprise. They’ll have far fewer choices than in previous years — and will have a harder time getting assistance purchasing a plan. The program’s cost to taxpayers, meanwhile, have soared. What ...
Business & Economics
Basel Accord’s expanded banking rules could tank Trump’s economy — unless he acts fast
Since Congress passed President Donald Trump’s “One Big Beautiful Bill” this summer, strong real-GDP growth has combined with minimal inflation, boosting American prosperity. But one potential misstep could end this decisive, action-oriented administration’s hope of making the American economy great again — while losing the midterm elections and Republican control ...
Commentary
Health Insurers Are Behind Washington’s Shutdown
The federal government shutdown is entering its fifth week. At its core, the fight is over insurance subsidies. Democrats are demanding that billions in federal payments to insurers continue uninterrupted. Republicans question whether that’s a good idea. Democrats claim they’re protecting “access to care.” In reality, they’re enriching some of ...
Commentary
Medicare Can’t Afford Not To Cover Ozempic
The Trump administration has yet to decide whether Medicare will cover a revolutionary new class of weight-loss treatments, which include drugs like Zepbound and Wegovy. But a decision could be imminent, according to Dr. Mehmet Oz, head of the Centers for Medicare and Medicaid Services. Speaking at an event at ...
Commentary
Another Program Won’t Secure Quality Rural Healthcare
In rural America, quality medical care can be hard to come by. The Rural Health Transformation Program that’s part of the budget reconciliation package that became law this summer aims to change that. The $50 billion program seeks to improve healthcare access, quality, and outcomes in rural America. All worthy ...
Commentary
Enhanced Obamacare subsidies are the problem
Democrats are refusing to reopen the federal government unless Congress extends the enhanced Obamacare premium subsidies scheduled to expire at the end of this year. Their ultimate goal is to make those subsidies permanent. The shutdown’s architects say that failing to renew these tax credits will threaten the finances of ...
340B Drug Pricing Program Overdue for Reform, GOP Can Help
Members of the Senate Health, Education, Labor, and Pensions Committee held a hearing in October to discuss a federal healthcare policy long overdue for reform — the 340B Drug Pricing Program. Created to expand access to affordable medicines for low-income people, 340B has since fallen victim to rampant abuse by ...
Medicare’s Paltry Doctor Payments Are Price Controls In Disguise
Specialist physicians will receive a significant pay cut from Medicare next year. That’s the main takeaway from the 2026 physician fee schedule released by the Centers for Medicare and Medicaid Services in October. For years, physician reimbursement from Medicare has stagnated, even declined. Doctors are responding by leaving the profession ...
Restricting Capital Investment Is A Losing Energy Strategy
The U.S. energy grid stands at a crossroads. It is facing an unprecedented rise in electricity demand driven in no small part by the growth of artificial intelligence and high-tech manufacturing. Simultaneously, supply is being curtailed by growing power plant retirements. It doesn’t take an advanced degree in economics to ...
No, the expiring subsidies aren’t to blame for next year’s premium hikes
Open enrollment on Obamacare‘s exchanges is upon us. People shopping for coverage will be greeted by higher premiums. According to one recent analysis from the Peterson-KFF Health System Tracker, premiums for 2026 coverage will rise by 18 %. Out-of-pocket costs could go up hundreds or thousands of dollars, according to ...
Medicare Wasn’t Broken Until Democrats Made It That Way
Seniors shopping for a prescription drug plan during this year’s Medicare open enrollment season are in for an unpleasant surprise. They’ll have far fewer choices than in previous years — and will have a harder time getting assistance purchasing a plan. The program’s cost to taxpayers, meanwhile, have soared. What ...
Basel Accord’s expanded banking rules could tank Trump’s economy — unless he acts fast
Since Congress passed President Donald Trump’s “One Big Beautiful Bill” this summer, strong real-GDP growth has combined with minimal inflation, boosting American prosperity. But one potential misstep could end this decisive, action-oriented administration’s hope of making the American economy great again — while losing the midterm elections and Republican control ...
Health Insurers Are Behind Washington’s Shutdown
The federal government shutdown is entering its fifth week. At its core, the fight is over insurance subsidies. Democrats are demanding that billions in federal payments to insurers continue uninterrupted. Republicans question whether that’s a good idea. Democrats claim they’re protecting “access to care.” In reality, they’re enriching some of ...
Medicare Can’t Afford Not To Cover Ozempic
The Trump administration has yet to decide whether Medicare will cover a revolutionary new class of weight-loss treatments, which include drugs like Zepbound and Wegovy. But a decision could be imminent, according to Dr. Mehmet Oz, head of the Centers for Medicare and Medicaid Services. Speaking at an event at ...
Another Program Won’t Secure Quality Rural Healthcare
In rural America, quality medical care can be hard to come by. The Rural Health Transformation Program that’s part of the budget reconciliation package that became law this summer aims to change that. The $50 billion program seeks to improve healthcare access, quality, and outcomes in rural America. All worthy ...
Enhanced Obamacare subsidies are the problem
Democrats are refusing to reopen the federal government unless Congress extends the enhanced Obamacare premium subsidies scheduled to expire at the end of this year. Their ultimate goal is to make those subsidies permanent. The shutdown’s architects say that failing to renew these tax credits will threaten the finances of ...
